Hyderabad-based Zenara Pharma has launched a generic version of Pfizer’s COVID-19 oral drug Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets).
First to do so in the country, it has launched Nirmatrelvir and Ritonavir tablets in a combi pack for patients with mild to moderate symptoms of COVID-19. The product will be sold under the brand name, Paxzen.
The maximum retail price will be ₹5,200 per box, containing 20 tablets of Nirmatrelvir 150mg and 10 tablets of Ritonavir 100mg or equivalent to one full course of treatment per patient, Zenara Pharma said on September 9. The company had in August received approval from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market the product.
